SIT AND DELIVER

Long-Acting Injectable Formulations Targeting Opioid Overdose With Elysium's Tom Jenkins
Not only do opioid overdose sufferers need urgent, rescue treatments but they often remain vulnerable to symptom rebound and continued opioid use disorder (OUD). In this episode of Sit and Deliver, Tom Jenkins, Chief Scientific Officer of biopharmaceutical compan...
ABOUT SIT AND DELIVER
Created for stakeholders across the drug delivery landscape, from sponsor companies to regulatory agencies, Sit and Deliver offers timely insights from leading thinkers on drug delivery trends, movements, opportunities, and challenges.
MEET YOUR HOST

On each episode of Sit and Deliver, Drug Delivery Leader Chief Editor Tom von Gunden frames a topic of interest and impact to drug delivery professionals and invites a guest commentator to “deliver” perspectives on that focused topic.
Interested in joining Tom on an episode? Contact him today.